drugset / Trial / NCT01384214
Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate swallowing efficiency in patients with cervical dystonia following treatment with botulinum toxin Type A.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 750 iu | — |